血塞通注射液干预脑梗死患者的临床相关指标影响分析

Abstract: Objective To investigate the effect of Xuesaitong Injection (XSTI) on clinically relevant indicators in patients with cerebral infarction (CI). Methods A total of 60 inpatients with cerebral infarction admitted from June 2024 to June 2025 were selected and divided into two groups using a random number table method:the experimental group (30 cases) and the control group (30 cases). Patients in the control group received conventional treatment, while those in the experimental group received intravenous infusion of Xuesaitong Injection in addition to the conventional treatment of the control group. The clinical efficacy of the two groups was evaluated. Results Ten days after treatment, the neurological deficit (NIHSS) score of the experimental group was significantly lower than that of the control group, and the Barthel Index (daily living ability score) was significantly higher than that of the control group (P＜0.05). In terms of laboratory indicators, the whole blood low-shear viscosity, plasma viscosity, high-sensitivity c-reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α) and other indicators in the experimental group were significantly lower than those in the control group, with statistically significant differences (P＜0.05). Conclusion Xuesaitong Injection combined with conventional therapy can improve the neurological function and daily living ability of patients with cerebral infarction, regulate the hemorheological state, and reduce the inflammatory response, with definite clinical efficacy.